Published in:
01-06-2021 | Echocardiography | Editorial
Low-dose gated bloodpool SPECT: Is it time to make the shift?
Authors:
Laetitia Imbert, PhD, Pierre-Yves Marie, MD, PhD
Published in:
Journal of Nuclear Cardiology
|
Issue 3/2021
Login to get access
Excerpt
Left ventricular radionuclide angiography (RNA) has been extensively used in the past for the assessment of prognosis and therapy in various ischemic and non-ischemic cardiomyopathies. In these indications, however, RNA has been progressively replaced by other cardiac imaging modalities, in particular by echocardiography. From a practical standpoint, most planar RNA are nowadays performed for the serial monitoring of left ventricular ejection fraction (LVEF) in patients with potentially cardiotoxic chemotherapies,
1 even though echocardiography is also the most widely accepted imaging method in this indication.
2,
3 …